These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 1505141)

  • 1. Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.
    Lønning PE; Lien EA; Lundgren S; Kvinnsland S
    Clin Pharmacokinet; 1992 May; 22(5):327-58. PubMed ID: 1505141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormone therapy for breast cancer].
    Uramoto H; Kagami S; Iwashige A; Tsukada J
    J UOEH; 2006 Sep; 28(3):287-94. PubMed ID: 16981405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine treatment of advanced breast cancer.
    Dowsett M
    Acta Oncol; 1996; 35 Suppl 5():68-72. PubMed ID: 9142970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel endocrine therapies in breast cancer.
    Klijn JG; Setyono-Han B; Bontenbal M; Seynaeve C; Foekens J
    Acta Oncol; 1996; 35 Suppl 5():30-7. PubMed ID: 9142962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic manipulation of steroid hormones. Adjunctive therapies in cancer of the breast.
    Manni A
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):825-44. PubMed ID: 1778179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.
    Lundgren S; Lønning PE; Aakvaag A; Kvinnsland S
    Cancer Chemother Pharmacol; 1990; 27(2):101-5. PubMed ID: 2249324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of anti-endocrine agents.
    Lønning PE; Lien EA
    Cancer Surv; 1993; 17():343-70. PubMed ID: 8137347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New endocrine approaches in the treatment of breast cancer.
    von Minckwitz G; Kaufmann M
    Biomed Pharmacother; 1998; 52(3):122-32. PubMed ID: 9755805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress of endocrine therapy in breast cancer].
    Nomura Y
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):783-9. PubMed ID: 1605654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on endocrine therapy for breast cancer.
    Buzdar AU; Hortobagyi G
    Clin Cancer Res; 1998 Mar; 4(3):527-34. PubMed ID: 9533518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New developments in hormonal therapy for breast cancer].
    Tominaga T
    Gan To Kagaku Ryoho; 1996 May; 23(6):678-83. PubMed ID: 8645017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary experience with pure antiestrogens.
    Howell A
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4369s-4375s; discussion 4411s-4412s. PubMed ID: 11916227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine therapies of breast cancer.
    Goldhirsch A; Gelber RD
    Semin Oncol; 1996 Aug; 23(4):494-505. PubMed ID: 8757275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New hormonal therapies].
    Spielmann M
    Bull Cancer; 1994; 81(10 Suppl):8-10. PubMed ID: 7718951
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine therapy of metastatic breast cancer.
    Manni A
    J Endocrinol Invest; 1989 May; 12(5):357-72. PubMed ID: 2570093
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormonal therapy of breast carcinoma in women].
    Possinger K; Classen S; Beykirch M; Flath B; Wilmanns W
    Dtsch Med Wochenschr; 1991 Dec; 116(50):1921-9. PubMed ID: 1748071
    [No Abstract]   [Full Text] [Related]  

  • 18. Second-line endocrine treatment of advanced breast cancer--a randomized cross-over study of medroxy-progesterone acetate and aminoglutethimide.
    Hultborn R; Johansson-Terje I; Bergh J; Glas U; Hallsten L; Hatschek T; Holmberg E; Ideström K; Norberg B; Ranstam J; Söderberg M; Wallgren UB
    Acta Oncol; 1996; 35 Suppl 5():75. PubMed ID: 9142972
    [No Abstract]   [Full Text] [Related]  

  • 19. [Which hormone therapy should be used in advanced breast carcinoma in males?].
    Lönning PE; Wiedemann G; Kvinnsland S; Lundgren S
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1358-61. PubMed ID: 2970379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
    Jordan VC; Brodie AM
    Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.